---
title: "很多人喜欢用“细胞-细胞间交互”报国自然，但是太多坑了……"
date: 2024-10-28T00:03:13Z
draft: ["false"]
tags: [
  "fetched",
  "小张聊科研"
]
categories: ["Acdemic"]
---
很多人喜欢用“细胞-细胞间交互”报国自然，但是太多坑了…… by 小张聊科研
------
<div><section><img data-backh="224" data-backw="578" data-imgfileid="508329528" data-ratio="0.387037037037037" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtwG0fArf2vj63L6TuvYiaHr4uOoewe9cWKQ3Q3MgG4mE590ZIOHAUyticiaiaV8DXF8v31O7kalNBBd8g/640?wx_fmt=other&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type="other" data-w="1080" src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtwG0fArf2vj63L6TuvYiaHr4uOoewe9cWKQ3Q3MgG4mE590ZIOHAUyticiaiaV8DXF8v31O7kalNBBd8g/640?wx_fmt=other&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><p><span>“细</span><span>胞-细胞间交互”是国自然项目中大家经常涉及的思路，当然现在细胞器之间的通讯也是新的方向（</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655813038&amp;idx=1&amp;sn=ae4c48ef167e7d06eae6bad226a5fb87&amp;chksm=808fa190b7f8288639210691c15259eb77f64a99b0ca097f7c2791ca61506843429de43d5ead&amp;scene=21#wechat_redirect" textvalue="国自然思路|“细胞间交互”创新性不好？那看看“细胞器间交互”吧！" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2"><strong><span>国自然思路|“细胞间交互”创新性不好？那看看“细胞器间交互”吧！</span></strong></a><span>）</span><span lang="EN-US">，</span><strong><span>虽然</span><span lang="EN-US">“</span><span>细胞</span><span lang="EN-US">-</span><span>细胞间交互</span><span lang="EN-US">”</span><span>这个问题理解起来很容易，实际上在国自然申请和研究执行过程中的问题非常多，而这些问题只是通过看文章是看不出来的。</span></strong><span></span></p><p><strong><span><span>说明：</span></span></strong><span>之前我们也发过另外一期“</span><span><span><strong>研究细胞死亡的坑</strong></span></span><span><span>”</span>的推文：</span><span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655810709&amp;idx=3&amp;sn=1264a4d6853b0b027c4e8414d49a5734&amp;chksm=808fa8abb7f821bd10a6eaf956b334c07d62376a9d4d4c06f47e6c1715cad89c17f00c7edab1&amp;scene=21#wechat_redirect" textvalue="研究细胞死亡的注意了：如果这个问题考虑不到，基金很大概率被毙！" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span><strong>研究细胞死亡的注意了：如果这个问题考虑不到，基金很大概率被毙！</strong></span></a>其实绝大多数方向都有很多坑，<span><strong>大家粗看起来都是平坦大道，实际走起来问题都非常非常多，一不小心就会掉进坑里，本子被毙……</strong></span></span></p><p><span>因此我们本期重点说“细胞</span><span lang="EN-US">-</span><span>细胞间交互”这个主题下大家比较常用的一种思路——</span><strong><span>基于“配体</span><span lang="EN-US">-</span><span>受体互作”的细胞间交互</span></strong><span>（当然还有很多其它方式）。基于“配体</span><span lang="EN-US">-</span><span>受体互作”的细胞间交互是大家接触最多的一种方式，即“</span><span><strong><span>细胞</span><span lang="EN-US">1</span><span>上的配体</span><span lang="EN-US">A</span><span>通过与细胞</span><span lang="EN-US">2</span><span>上的受体</span><span lang="EN-US">B</span><span>结合，从而调控细胞</span><span lang="EN-US">2</span><span>的信号通路以及下游的表型</span></strong></span><span>”。</span><span lang="EN-US"><p></p></span></p><p><img data-imgfileid="508329529" data-ratio="0.42783505154639173" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVWwWUYFicgISnTugEjGNRDID3YslUngMKpyTibuKHpzxDEsSxLHariajdEA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="582" src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVWwWUYFicgISnTugEjGNRDID3YslUngMKpyTibuKHpzxDEsSxLHariajdEA/640?wx_fmt=png&amp;from=appmsg"><span lang="EN-US"></span><span lang="EN-US"><p></p></span></p><p><span>比如</span><strong><span>巨噬细胞（细胞</span><span lang="EN-US">1</span><span>）分泌</span><span lang="EN-US">TGF</span><span>β（配体</span><span lang="EN-US">A</span><span>）后结合上皮细胞（细胞</span><span lang="EN-US">2</span><span>）上的</span><span lang="EN-US">TGF</span><span>β的受体</span><span lang="EN-US">TGF</span><span>β</span><span lang="EN-US">R</span><span>，从而激活上皮细胞</span><span lang="EN-US">TGF</span><span>β</span><span lang="EN-US">R</span><span>下游通路（比如</span><span lang="EN-US">SMAD</span><span>通路），然后导致上皮细胞转录谱变化、</span><span lang="EN-US">EMT</span><span>等等表型</span></strong><span>。</span><span lang="EN-US"><p></p></span></p><p><img data-galleryid="" data-imgfileid="508329534" data-ratio="0.3125" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVWsXgrmkcYyY49PFGoCSibrS8TpCqVKLKaicZKGTgdWBJuq5ojw4noXAlw/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1024" src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVWsXgrmkcYyY49PFGoCSibrS8TpCqVKLKaicZKGTgdWBJuq5ojw4noXAlw/640?wx_fmt=png&amp;from=appmsg"></p><p><span>当然反过来说，上皮细胞也可以用类似的方式影响巨噬细胞，从而形成“巨噬细胞</span><span lang="EN-US">-</span><span>上皮细胞”通讯的反馈回路，最终“</span><span><strong><span>共同选择和进化</span></strong></span><span>”。</span><strong><span lang="EN-US"><p></p></span></strong></p><p><span>进行这种方式研究的细节问题非常多，我们大致说四点：</span><span lang="EN-US"><p></p></span></p><p><span lang="EN-US">1.</span><span>大部分申请人这么设计基于的是<strong><span>单细胞测序中</span></strong></span><strong><span lang="EN-US">CellChat</span></strong><strong><span>等细胞通讯</span></strong><span>的分析方法，但关键在于“</span><span><span><strong>基于</strong></span><strong><span lang="EN-US">CellChat</span></strong><strong><span>分析得到的配体和受体并不一定是有差异的</span></strong></span><span>”，所以很多人看到分析结果显示</span><span lang="EN-US">TGF</span><span>β</span><span lang="EN-US">-TGF</span><span>β</span><span lang="EN-US">R</span><span>的配体</span><span lang="EN-US">-</span><span>受体对在疾病组与对照组差异很大，<strong><span>但没有留意到</span></strong></span><strong><span lang="EN-US">TGFβ和TGFβR</span></strong><span><strong><span>在</span></strong></span><strong><span>两个细胞的表达上根本就没有显著差异</span></strong><span>，那后续怎么能验证出来？</span><span lang="EN-US"><p></p></span></p><p><img data-galleryid="" data-imgfileid="508329530" data-ratio="0.9526748971193416" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVW3MvYibicibbUgVpJ3gK3ocTkib9wia5iahLoHx2U00JT9lBUBFJxHEoKJxYQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="486" src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVW3MvYibicibbUgVpJ3gK3ocTkib9wia5iahLoHx2U00JT9lBUBFJxHEoKJxYQ/640?wx_fmt=png&amp;from=appmsg"></p><p><span lang="EN-US">2. </span><span>由于这些算法的大部分是基于“经验总结”，即根据之前文献报道归纳的配体</span><span lang="EN-US">-</span><span>受体互作关系对，</span><span><strong>因此通常鉴定到的配体与受体都是“老基因”</strong></span><span>，像</span><span lang="EN-US">TGF</span><span>β</span><span lang="EN-US">-</span><span>受体</span><span lang="EN-US">TGF</span><span>β</span><span lang="EN-US">R</span><span>等报道了很多的基因，因此如果想发现新的配体</span><span lang="EN-US">-</span><span>受体对关系实际上是不太可能的；</span><span lang="EN-US"><p></p></span></p><p><span lang="EN-US">3</span><span>）<strong><span>大部分的配体与受体关系<strong><span>对</span></strong>是多对多的，即配体有好几个，受体也有好几个</span></strong>，而由于配体与受体在功能上有冗余，即配体</span><span lang="EN-US">1</span><span>和配体</span><span lang="EN-US">2</span><span>的作用基本相似，而受体</span><span lang="EN-US">1</span><span>与受体</span><span lang="EN-US">2</span><span>的作用也相似，但是细胞</span><span lang="EN-US">2</span><span>最后的表型是受到受体</span><span lang="EN-US">1</span><span>和受体</span><span lang="EN-US">2</span><span>激活</span><span lang="EN-US">/</span><span>抑制后的综合体现。<strong><span>即受体</span></strong></span><strong><span lang="EN-US">2</span></strong><strong><span>是被激活了，但是受体</span></strong><strong><span lang="EN-US">1</span></strong><strong><span>被抑制了，那"加和效应<strong><span>"</span></strong>未必是申请人说的受体</span></strong><strong><span lang="EN-US">2</span></strong><strong><span>激活所体现出来的结果；而且即使受体</span></strong><strong><span lang="EN-US">2</span></strong><strong><span>的激活是由于配体</span></strong><strong><span lang="EN-US">1</span></strong><strong><span>增加导致的，那同样为受体</span></strong><strong><span lang="EN-US">2</span></strong><strong><span>配体的配体</span></strong><strong><span lang="EN-US">2</span></strong><strong><span>表达如何呢？</span></strong><span>这就会导致研究设计的问题非常多。</span><span lang="EN-US"><p></p></span></p><p><span>所以很多项目里面<strong>假说里面是这样的：</strong></span><span lang="EN-US"><p></p></span></p><p><img data-imgfileid="508329531" data-ratio="0.42783505154639173" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVWwWUYFicgISnTugEjGNRDID3YslUngMKpyTibuKHpzxDEsSxLHariajdEA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="582" src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVWwWUYFicgISnTugEjGNRDID3YslUngMKpyTibuKHpzxDEsSxLHariajdEA/640?wx_fmt=png&amp;from=appmsg"><span lang="EN-US"></span><span lang="EN-US"><p></p></span></p><p><span>但<strong>实际全貌是这样的：</strong></span><span lang="EN-US"><p></p></span></p><p><img data-imgfileid="508329532" data-ratio="0.6791044776119403" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVWazfh30HYn1FOfsDugbB5ucLFCUmKzYaTibghHEuyYkNKZjicm47a2wlg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="536" src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVWazfh30HYn1FOfsDugbB5ucLFCUmKzYaTibghHEuyYkNKZjicm47a2wlg/640?wx_fmt=png&amp;from=appmsg"><span lang="EN-US"></span><span lang="EN-US"><p></p></span></p><p><strong><span>所以问题在于“以偏概全”，如果你没有考虑到这些可能性并提供关键的预实验，研究设计是不是就不严谨？</span></strong><span lang="EN-US"><p></p></span></p><p><span lang="EN-US">4) </span><span>这也是很致命的问题：</span><span><strong>配体与受体的表达并不只是在一种细胞上</strong></span><span>，比如前面我们说的</span><span lang="EN-US">TGF</span><span>β只表达在巨噬细胞上，而不能由</span><span lang="EN-US">T</span><span>细胞或者其它细胞表达吗？好，</span><strong><span>你说我只关注巨噬细胞上的</span><span lang="EN-US">TGF</span><span>β，那</span><span lang="EN-US">TGF</span><span>β的受体</span><span lang="EN-US">TGF</span><span>β</span><span lang="EN-US">R</span><span>就只在上皮细胞上么？</span></strong><span>所以这里又有一个很重要的“贡献量化”的问题：</span><span><strong><span>证明巨噬细胞来源的</span><span lang="EN-US">TGF</span><span>β是上皮细胞上受体</span><span lang="EN-US">TGF</span><span>β</span><span lang="EN-US">R</span><span>激活的必要和主要方式，所以也要提供关键的预实验证据。</span></strong></span><span lang="EN-US"><p></p></span></p><p><img data-galleryid="" data-imgfileid="508329536" data-ratio="1.4051724137931034" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVWzABc3WiceTjSWfRgsXIBrRWpV6fibD8lnyepjLbia0YQw2tZ4HIoxVZZA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="464" src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtyttTiaicmgkuoxNuCWxkxTVWzABc3WiceTjSWfRgsXIBrRWpV6fibD8lnyepjLbia0YQw2tZ4HIoxVZZA/640?wx_fmt=png&amp;from=appmsg"></p><p><br></p><section><strong><span>基金申请或者课题思路疑问，联系咨询扫码：</span></strong></section><p><img data-backh="292" data-backw="283" data-imgfileid="508329538" data-ratio="1.0318021201413428" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtzuxV7WPb3cR11TUOdrIqvNiavxNVHJma1gUepmRicvxPo0ibSJY5VX5zd5uqFY71yNIlbQWeFTY8AYA/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-type="png" data-w="283" src="https://mmbiz.qpic.cn/sz_mmbiz_png/W1UqIxJECtzuxV7WPb3cR11TUOdrIqvNiavxNVHJma1gUepmRicvxPo0ibSJY5VX5zd5uqFY71yNIlbQWeFTY8AYA/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></p><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/KuOU4SgLP0zDe6w5fBXo0Q",target="_blank" rel="noopener noreferrer">原文链接</a>
